Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents.
Based on an international consensus conference held in Copenhagen in the autumn of 1994, a set of guidelines for Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents are presented. The guidelines are intended to be a help for people working in this research field, and it is hoped that the guidelines will assist researchers, editors, and drug companies to enhance the quality of their pharmacodynamic studies of neuromuscular blocking agents.
Viby-Mogensen
J
J
Department of Anaesthesia and Intensive Care, National University Hospital, Rigshospitalet, Copenhagen, Denmark.
Engbaek
J
J
Eriksson
L I
LI
Gramstad
L
L
Jensen
E
E
Jensen
F S
FS
Koscielniak-Nielsen
Z
Z
Skovgaard
L T
LT
Ostergaard
D
D
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004576:Electromyography; D006801:Humans; D007442:Intubation, Intratracheal; D008991:Monitoring, Physiologic; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects
D009466:Neuromuscular Blocking Agents